Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Schedule of Intangible Assets Intangible Asset and Goodwill [Table Text Block] Trading Arrangement: Trading Arrangement [Axis] Maximum Maximum [Member] Statistical Measurement [Domain] Statistical Measurement [Domain] Cash and Cash Equivalents Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block] Settlement of Vested Stock Options Settlement Of Vested Stock Options [Member] Settlement Of Vested Stock Options Title of 12(b) Security Title of 12(b) Security Subsequent Event Subsequent Event [Member] Numerator for diluted EPS — net income Net Income (Loss) Available to Common Stockholders, Diluted Document Fiscal Year Focus Document Fiscal Year Focus Acquisition-related cost, expense Business Combination, Acquisition-Related Cost, Expense Prosigna Prosigna [Member] Prosigna Total cost of revenue Cost Of Revenue, Including Amortization Cost Of Revenue, Including Amortization Adjustment to Compensation, Amount Adjustment to Compensation Amount Financial Instrument [Axis] Financial Instrument [Axis] Loss on deconsolidation of subsidiary Loss on deconsolidation of subsidiary Deconsolidation, Gain (Loss), Amount Customer [Axis] Customer [Axis] Segment Reporting [Abstract] Schedule of Future Aggregate Amortization Expense Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense [Table Text Block] Common stock, $0.001 par value; 125,000,000 shares authorized, 80,655,975 and 79,359,005 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively Common Stock, Value, Issued 2027 Lessee, Operating Lease, Liability, to be Paid, Year One Payment of taxes on vested restricted stock units Payment, Tax Withholding, Share-Based Payment Arrangement Accrued compensation expenses Employee-related Liabilities, Current Restatement Determination Date Restatement Determination Date Biopharmaceutical revenue Biopharmaceutical And Other - Biopharmaceutical Revenue [Member] Biopharmaceutical And Other - Biopharmaceutical Revenue Amendment Flag Amendment Flag Goodwill [Line Items] Goodwill [Line Items] Current liabilities: Liabilities, Current [Abstract] Entity Common Stock, Shares Outstanding (in shares) Entity Common Stock, Shares Outstanding Developed technology Developed Technology Rights [Member] Compensation expense Cost Of Revenue, Compensation Expense Cost Of Revenue, Compensation Expense Property, plant and equipment, net Business Combination, Recognized Asset Acquired, Property, Plant, and Equipment Treasury bills Treasury bills US Treasury Bill Securities [Member] Decipher Decipher [Member] Decipher Other cost Other Cost of Operating Revenue Loss Contingencies [Table] Loss Contingencies [Table] Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax [Abstract] Schedule of Short-Term Investments Debt Securities, Held-to-Maturity [Table Text Block] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Business Combination, Consideration Transferred, Cash Consideration Type [Domain] Business Combination, Consideration Transferred, Cash Consideration Type [Domain] Business Combination, Consideration Transferred, Cash Consideration Type [Domain] Entity Address, State or Province Entity Address, State or Province PEO Total Compensation Amount PEO Total Compensation Amount Common stock, par value (in USD per share) Common Stock, Par or Stated Value Per Share Assets Assets, Fair Value Disclosure [Abstract] Intangible assets, net Intangible assets, net Intangible Asset, Excluding Goodwill, after Accumulated Amortization Basic (in shares) Denominator for basic EPS — weighted average shares (in shares) Weighted Average Number of Shares Outstanding, Basic Amortization of discount on short-term investments Accretion (Amortization) of Discounts and Premiums, Investments Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Loss Contingencies [Line Items] Loss Contingencies [Line Items] Number of reporting segments Number of Reportable Segments Total current liabilities Liabilities, Current 2030 Lessee, Operating Lease, Liability, to be Paid, Year Four Customer relationships Customer Relationships [Member] Biopharmaceutical and other revenue Biopharmaceutical And Other [Member] Represents biopharmaceutical. Entity Address, City or Town Entity Address, City or Town Amounts Placed in Escrow Amounts Placed In Escrow [Member] Amounts Placed In Escrow Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Class of Stock [Axis] Class of Stock [Axis] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Product revenue Product [Member] Net Carrying Amount Intangible Asset, Finite-Lived, after Accumulated Amortization Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Numerator for basic EPS — net income Net Income (Loss) Available to Common Stockholders, Basic Revenue Revenue from Contract with Customer Benchmark [Member] Accrued liabilities and deferred revenue Increase (Decrease) In Accrued Liabilities And Deferred Revenue Increase (Decrease) In Accrued Liabilities And Deferred Revenue Level II Fair Value, Inputs, Level 2 [Member] Accumulated Amortization Accumulated Amortization Intangible Asset, Finite-Lived, Accumulated Amortization Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Business Combination, Consideration Transferred, Cash Consideration Type [Axis] Business Combination, Consideration Transferred, Cash Consideration Type [Axis] Business Combination, Consideration Transferred, Cash Consideration Type Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Probability of achievement Measurement Input, Probability Of Achievement [Member] Measurement input using probability of achievement. Subsequent Event Type [Axis] Subsequent Event Type [Axis] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Allocation of facilities and IT expenses Cost Of Revenue, Allocation Of Facilities And Information Technology Expenses Cost Of Revenue, Allocation Of Facilities And Information Technology Expenses Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Purchases of property, plant and equipment included in accounts payable and accrued liability Capital Expenditures Incurred but Not yet Paid Schedule of Segment Reporting Information, by Segment Segment Reporting [Table Text Block] Loss on disposal of property, plant and equipment Gain (Loss) on Disposition of Property Plant Equipment Use of Estimates Use of Estimates, Policy [Policy Text Block] Revenue Recognition and Cost of Revenue Revenue from Contract with Customer [Policy Text Block] Other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Noncash lease expense Noncash Lease Expense The noncash portion of lease expense. Schedule of Future Minimum Lease Payments Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Document Period End Date Document Period End Date Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Net cash used in investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding 2028 Lessee, Operating Lease, Liability, to be Paid, Year Two Stockholders' Equity Equity [Text Block] Security Exchange Name Security Exchange Name Phil Febbo Trading Arrangement, Common Stock [Member] Phil Febbo Trading Arrangement, Common Stock Medicare Medicare [Member] Represents Medicare. Allocation of facilities and IT expenses Operating Expenses, Allocation Of Facilities And Information Technology Expenses Operating Expenses, Allocation Of Facilities And IT Expenses Business Combination, Separately Recognized Transaction [Axis] Business Combination, Separately Recognized Transaction [Axis] Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Shell Company Entity Shell Company Current portion of operating lease liabilities Less: short-term lease liabilities Operating Lease, Liability, Current Statement of Comprehensive Income [Abstract] Trademarks and tradenames Trademarks and Trade Names [Member] Net Income Per Common Share Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name Earnings per share: Earnings Per Share [Abstract] Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Document Fiscal Period Focus Document Fiscal Period Focus Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Common stock equivalent shares excluded from the dilutive calculation due to antidilutive effect: Antidilutive Securities Excluded From Computation Of Earnings Per Share [Abstract] Antidilutive Securities Excluded From Computation Of Earnings Per Share Total liabilities Liabilities Trading Symbol Trading Symbol Shares of common stock subject to outstanding options Employee And Non-Employee Stock Option [Member] An arrangement whereby an employee or non-employee is entitled to receive in the future, subject to vesting and other restrictions, number of shares in the entity at a specified price, as defined in the agreement. Discount rate Measurement Input, Discount Rate [Member] Intangible Asset, Including Goodwill, after Accumulated Amortization [Abstract] Intangible Asset, Including Goodwill, after Accumulated Amortization [Abstract] Indefinite-lived intangible assets Intangible Asset, Excluding Goodwill, Indefinite-Lived Purchases of property, plant and equipment Payments to Acquire Property, Plant, and Equipment Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Interest expense Other Nonoperating Income (Expense), Interest Expense Interest Expense, Nonoperating Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Schedule of Fair Values of Assets Acquired and Liabilities Assumed Business Combination, Recognized Asset Acquired and Liability Assumed [Table Text Block] Company Selected Measure Name Company Selected Measure Name Income Tax Disclosure [Abstract] Intangible Asset, Indefinite-Lived [Table] Intangible Asset, Indefinite-Lived [Table] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Compensation Amount Outstanding Recovery Compensation Amount Individual: Individual [Axis] Equity interest acquired Business Combination, Voting Equity Interest Acquired, Percentage Intangible Asset, Indefinite-Lived [Line Items] Intangible Asset, Indefinite-Lived [Line Items] Diluted (in shares) Denominator for diluted EPS — adjusted weighted average shares and assumed conversions (in shares) Weighted Average Number of Shares Outstanding, Diluted Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Entity Emerging Growth Company Entity Emerging Growth Company Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Net identifiable assets acquired Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less) Underlying Security Market Price Change Underlying Security Market Price Change, Percent Property, plant and equipment, net Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization Thereafter Intangible Asset, Finite-Lived, Estimated Amortization Expense, After Year Four Intangible Asset, Finite-Lived, Estimated Amortization Expense, After Year Four Gross Unrealized Holding Losses Debt Securities, Held-to-Maturity, Accumulated Unrecognized Loss Less: amount representing interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Other assets Increase (Decrease) in Other Noncurrent Assets Phil Febbo Trading Arrangement, Vested Restricted Stock Units (RSUs) [Member] Phil Febbo Trading Arrangement, Vested Restricted Stock Units (RSUs) Gross profit Gross Profit Other general and administrative expenses Other General and Administrative Expense Cash paid for amounts included in the measurement of lease liabilities Operating Lease, Payments Cost of revenue: Cost of Revenue [Abstract] Award Timing Predetermined Award Timing Predetermined [Flag] Direct expense Direct Operating Expenses Direct Operating Expenses Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Level I Fair Value, Inputs, Level 1 [Member] In-process research and development Software, Internally Developed [Member] Schedule of Third-party Payers as a Percentage of Total Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Organization, Consolidation and Presentation of Financial Statements [Abstract] Indefinite-lived Intangible Assets, Major Class Name [Domain] Intangible Asset, Indefinite-Lived, Class [Domain] Covergent Genomic Covergent Genomic [Member] Covergent Genomic Total future minimum lease payments Lessee, Operating Lease, Liability, to be Paid Dilutive potential common shares (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements All Executive Categories All Executive Categories [Member] Operating lease liabilities Increase (Decrease) in Operating Lease Liability Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Preferred stock, par value (in USD per share) Preferred Stock, Par or Stated Value Per Share Antidilutive Securities [Axis] Antidilutive Securities [Axis] Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract] Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract] Selling and marketing Total selling and marketing Selling and Marketing Expense Right-of-use assets, operating leases Operating Lease, Right-of-Use Asset Concentration Risk Type [Domain] Concentration Risk Type [Domain] Schedule of Computation of Basic and Diluted Net Earnings Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Total purchase price Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less), and Goodwill Fair Value Disclosures [Abstract] Segment Segment Reporting [Text Block] Minimum Minimum [Member] Expiration Date Trading Arrangement Expiration Date (Decrease) increase in cash, cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation Fair Value of Milestone Payments Fair Value Of Milestone Payments [Member] Fair Value Of Milestone Payments Schedule of Revenue Disaggregation of Revenue [Table Text Block] Gross Unrealized Holding Gains Debt Securities, Held-to-Maturity, Accumulated Unrecognized Gain Effect of foreign currency on cash, cash equivalents and restricted cash Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Shares used to compute earnings per common share: Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Location, Statement of Income, Balance [Axis] Location, Statement of Income, Balance [Axis] Restricted cash Restricted Cash and Cash Equivalent Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Issuance of common stock upon exercise of stock options and vesting of restricted stock units Share-Based Compensation Arrangement By Share-Based Payment Award, Value, Options And Non-Option Equity Instruments, Exercises In Period Share-Based Compensation Arrangement By Share-Based Payment Award, Value, Options And Non-Option Equity Instruments, Exercises In Period Business Combination [Line Items] Business Combination [Line Items] Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Other Income and Expenses [Abstract] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Accounts Receivable Business Combination, Recognized Asset Acquired, Receivable, Current Weighted Average Remaining Amortization Period (Years) Intangible Asset, Finite-Lived, Useful Life Components of Other Income Other Nonoperating Income and Expense [Text Block] Exercise Price Award Exercise Price Short-term investments Amortized Cost Debt Securities, Held-to-Maturity, Excluding Accrued Interest, after Allowance for Credit Loss Segment Reporting [Line Items] Segment Reporting [Line Items] Percepta Percepta [Member] Percepta Document Quarterly Report Document Quarterly Report Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Segments [Domain] Segments [Domain] Stock-based compensation expense (employee) Adjustments To Additional Paid In Capital, Share Based Compensation, Employee Amount of increase in additional paid-in capital (APIC) resulting from employee stock-based compensation expense. Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Business Combination [Table] Business Combination [Table] Equity Component [Domain] Equity Component [Domain] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Measurement Input Type [Domain] Measurement Input Type [Domain] Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract] Other assets Loans Receivable, Fair Value Disclosure Total operating expenses Costs and Expenses Adoption Date Trading Arrangement Adoption Date Schedule of Other Income, net Schedule of Other Nonoperating Income (Expense) [Table Text Block] Total stockholders’ equity Balance at beginning of period Balance at end of period Equity, Attributable to Parent Assets Assets [Abstract] Title Trading Arrangement, Individual Title Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Present value of future lease payments Operating Lease, Liability Insider Trading Policies and Procedures [Line Items] Stock options and restricted stock units issued and outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Fair Value Debt Securities, Held-to-Maturity, Fair Value Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Business Combination, Separately Recognized Transaction [Domain] Business Combination, Separately Recognized Transaction [Domain] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Balance Sheet Components Supplemental Balance Sheet Disclosures [Text Block] Interest income Other Nonoperating Income (Expense), Interest Income Other Nonoperating Income (Expense), Interest Income Business Combination [Domain] Business Combination [Domain] Deposits Security Deposit Seller Transaction Costs Seller Transaction Costs [Member] Seller Transaction Costs Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Anti-dilutive potential common shares (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Number of operating segments Number of Operating Segments Restricted stock units Restricted Stock Units (RSUs) [Member] Schedule of Goodwill Acquired Goodwill [Table Text Block] Entity Central Index Key Entity Central Index Key Weighted Average Weighted Average [Member] Additional paid-in capital Additional Paid in Capital, Common Stock All Adjustments to Compensation All Adjustments to Compensation [Member] Business Combination [Axis] Business Combination [Axis] Equity [Abstract] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Net cash provided by operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Accounts Receivable Accounts Receivable [Member] Convergent Genomics, Inc. Convergent Genomics, Inc. [Member] Convergent Genomics, Inc. Income Statement [Abstract] Income Statement [Abstract] Stockholders’ equity: Equity, Attributable to Parent [Abstract] Issuance of common stock under employee stock purchase plan (ESPP) (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Document Transition Report Document Transition Report Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Operating expenses: Operating Expenses [Abstract] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] UnitedHealthcare United Healthcare [Member] Represents United Healthcare. City Area Code City Area Code Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] All Individuals All Individuals [Member] Name Forgone Recovery, Individual Name Acquisition-related contingent consideration, net of current portion Business Combination, Contingent Consideration, Liability, Noncurrent Balance Sheet Related Disclosures [Abstract] Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Statement [Line Items] Statement [Line Items] Total assets Assets Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Total number of shares reserved for issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Issuance of common stock under employee stock purchase plan (ESPP) Stock Issued During Period, Value, Employee Stock Purchase Plan Annual license fee payments Business Combination, Consideration Transferred, Annual License Fee Payment Business Combination, Consideration Transferred, Annual License Fee Payment PEO PEO [Member] Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Concentrations of Credit Risk and Other Risks and Uncertainties Concentrations Of Credit And Other Risks And Uncertainties [Policy Text Block] Disclosure of accounting policy for concentrations of credit risk and other risks and uncertainties. Thereafter Lessee, Operating Lease, Liability, To Be Paid, Due After Year Four Lessee, Operating Lease, Liability, To Be Paid, Due After Year Four Other liabilities Other Liabilities, Noncurrent Goodwill Goodwill, beginning balance Goodwill, ending balance Goodwill Goodwill Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Goodwill acquired Goodwill, Acquired During Period Deferred income taxes Other Noncash Deferred Income Tax Expense (Benefit) Other Noncash Deferred Income Tax Expense (Benefit) Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Accounts payable Business Combination, Recognized Liability Assumed, Accounts Payable, Current Subsequent Event Type [Domain] Subsequent Event Type [Domain] Accumulated Deficit Retained Earnings [Member] Operating lease liabilities, net of current portion Long-term lease liabilities Operating Lease, Liability, Noncurrent Intangible asset amortization - operating expenses Intangible asset amortization - operating expenses Operating Expenses Money market funds Money Market Funds [Member] Issuance of common stock on exercise of stock options and vesting of restricted stock units (in shares) Share-Based Compensation Arrangement By Share-Based Payment Award, Options And Non-Option Equity Instruments, Exercises In Period Share-Based Compensation Arrangement By Share-Based Payment Award, Options And Non-Option Equity Instruments, Exercises In Period Cash and cash equivalents Business Combination, Recognized Asset Acquired, Cash and Cash Equivalent Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Schedule of Fair Value Measurement Inputs and Valuation Techniques Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Common stock, shares outstanding (in shares) Balance at beginning of period (in shares) Balance at end of period (in shares) Common Stock, Shares, Outstanding Award Timing Disclosures [Line Items] Schedule of Financial Instruments Measured at Fair Value Fair Value, by Balance Sheet Grouping [Table Text Block] Diluted (in USD per share) Diluted EPS (in USD per share) Earnings Per Share, Diluted Entity Current Reporting Status Entity Current Reporting Status Net cash used in financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Total Shareholder Return Amount Total Shareholder Return Amount Tax portion of vested restricted stock units Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Retention arrangements Business Combination, Separately Recognized Transaction, Acquisition-Related Cost, Debt and Equity Securities Issuance Cost, Not Expensed Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Gain (loss) on currency revaluation Other Nonoperating Income (Expense), Foreign Currency Translation Gain (Loss) Foreign Currency Translation Gain (Loss), Nonoperating Liabilities Liabilities, Fair Value Disclosure [Abstract] Intangible asset amortization - operating expenses Intangible Asset, Finite-Lived, Amortization Expense Intangible Asset, Finite-Lived [Line Items] Intangible Asset, Finite-Lived [Line Items] Research and development Total research and development Research and Development Expense Adjustments to reconcile net income to net cash provided by operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Total identifiable assets acquired Business Combination, Recognized Asset Acquired, Asset Intangible asset, finite-lived, acquired Fair Value Intangible Asset, Finite-Lived, Acquired Total revenue Revenue from Contract with Customer, Excluding Assessed Tax Financial Instruments [Domain] Financial Instruments [Domain] Customers Representing >10% Of Total Revenue Major Customers [Member] Major Customers Intangible Asset, Finite-Lived, Class [Axis] Intangible Asset, Finite-Lived, Class [Axis] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Underlying Securities Award Underlying Securities Amount Total intangible assets Intangible Asset, Excluding Goodwill, before Accumulated Amortization Non-cash loss on deconsolidation of subsidiary Non-Cash Deconsolidation, Gain (Loss), Amount Non-Cash Deconsolidation, Gain (Loss), Amount Discount rate Operating Lease, Weighted Average Discount Rate, Percent Intangible asset amortization - cost of revenue Cost, Amortization Segment Reporting [Table] Segment Reporting [Table] Shares available for issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Laboratory supplies and reagents expense Cost Of Revenue, Laboratory Supplies And Reagents Expense Cost Of Revenue, Laboratory Supplies And Reagents Expense Acquisition date Business Combination, Acquiree's Revenue since Acquisition Date, Actual Investing activities Cash Provided by (Used in) Investing Activity, Continuing Operation [Abstract] Schedule of Operating Lease Expense and Measurement Of Lease Liabilities Lease, Cost [Table Text Block] Current portion of acquisition-related contingent consideration Business Combination, Contingent Consideration, Liability, Current Operating activities Cash Provided by (Used in) Operating Activity, Continuing Operation [Abstract] Commitments and Contingencies Disclosure [Abstract] All Trading Arrangements All Trading Arrangements [Member] Other Performance Measure, Amount Other Performance Measure, Amount Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Income from operations Operating Income (Loss) Current Fiscal Year End Date Current Fiscal Year End Date Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Business Combination Business Combination [Text Block] Triggering Event [Axis] Triggering Event [Axis] Triggering Event Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Entity File Number Entity File Number Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Sample collection expense Cost Of Revenue, Sample Collection Expense Cost Of Revenue, Sample Collection Expense Indemnification Obligations Indemnification Obligations [Member] Indemnification Obligations Contingent consideration expense (reversal of expense) Business Combination, Contingent Consideration, Liability, Fair Value Adjustment Business Combination, Contingent Consideration, Liability, Fair Value Adjustment Impairment of assets Impairment loss Asset, Impairment Loss Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Common stock, shares issued (in shares) Common Stock, Shares, Issued Measure: Measure [Axis] Measurement input Combination, Intangible Asset, Measurement Input Combination, Intangible Asset, Measurement Input Equity Components [Axis] Equity Components [Axis] Accounts receivable Increase (Decrease) in Accounts Receivable Product and Service [Domain] Product and Service [Domain] Class of Stock [Line Items] Class of Stock [Line Items] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Entity Interactive Data Current Entity Interactive Data Current Operating loss Business Combination, Acquiree's Earnings (Loss) since Acquisition Date, Actual Deferred tax liabilities Deferred Income Tax Liabilities, Net Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Entity Small Business Entity Small Business Net comprehensive income Comprehensive Income (Loss), Net of Tax, Attributable to Parent 2029 Lessee, Operating Lease, Liability, to be Paid, Year Three Termination Date Trading Arrangement Termination Date Estimated Useful Life Intangible Asset, Finite-Lived, Acquired, Weighted-Average Amortization Period Accrued employee transaction bonuses and promised option payment Business Combination, Recognized Liability Assumed, Accrued Employee Transaction Bonuses And Promised Option Payment Business Combination, Recognized Liability Assumed, Accrued Employee Transaction Bonuses And Promised Option Payment Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Intangible assets, net Business Combination, Recognized Asset Acquired, Identifiable Intangible Asset, Finite-Lived Organization, Description of Business and Summary of Significant Accounting Policies Business Description and Accounting Policies [Text Block] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Manufacturing know-how Manufacturing Know-How [Member] Manufacturing Know-How Other assets Other Assets, Noncurrent Financing activities Cash Provided by (Used in) Financing Activity, Continuing Operation [Abstract] Document Type Document Type Business acquisitions, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Accrued liabilities Total accrued liabilities Accrued Liabilities, Current Fair Value as of Grant Date Award Grant Date Fair Value Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table] Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table] Number of patents allegedly infringed Loss Contingency, Patents Allegedly Infringed, Number Goodwill [Table] Goodwill [Table] Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Deferred revenue Business Combination, Recognized Liability Assumed, Deferred Revenue, Current Change in currency translation adjustments Currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Arrangement Duration Trading Arrangement Duration Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Local Phone Number Local Phone Number Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Registrant Name Entity Registrant Name Restricted Stock Units Retention Arrangements, Restricted Stock Units [Member] Retention Arrangements, Restricted Stock Units Income before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Commitments and contingencies Commitments and Contingencies Gross Carrying Amount Intangible Asset, Finite-Lived, before Accumulated Amortization Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] 2030 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Four Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Deferred purchase consideration recognized in connection with business acquisition Noncash or Part Noncash Acquisition, Payables Assumed Executive Category: Executive Category [Axis] Acquisitions Business Combination [Policy Text Block] Goodwill [Roll Forward] Goodwill [Roll Forward] Liabilities and Stockholders’ Equity Liabilities and Equity [Abstract] Intangible Asset, Finite-Lived, Class [Domain] Intangible Asset, Finite-Lived, Class [Domain] Trade names Trade Names [Member] Award Type [Domain] Award Type [Domain] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Remainder of 2026 Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Contract manufacturing and testing Biopharmaceutical And Other - Contract Manufacturing And Testing [Member] Biopharmaceutical And Other - Contract Manufacturing And Testing Fair Value Measurements Fair Value Disclosures [Text Block] Level III Fair Value, Inputs, Level 3 [Member] Supplies Increase (Decrease) in Materials and Supplies Supplementary cash flow information: Supplemental Cash Flow Information [Abstract] Other selling and marketing expenses Other Selling and Marketing Expense Reportable Segment Reportable Segment [Member] Reportable Segment 2027 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year One Release of accumulated translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax PEO Name PEO Name Restricted cash Restricted Cash Deferred revenue Contract with Customer, Liability Short-term investments, allowance for expected credit losses Debt Securities, Held-to-Maturity, Allowance for Credit Loss, Excluding Accrued Interest Cash paid for tax Income Tax Paid, before Refund Received Cash acquired from acquisition Cash Acquired from Acquisition Accrued Liabilities Business Combination, Recognized Liability Assumed, Accrued Liabilities, Current Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Entity Tax Identification Number Entity Tax Identification Number Measurement input Business Combination, Contingent Consideration, Liability, Measurement Input Other Other Nonoperating Income (Expense), Other Other Nonoperating Income (Expense), Other Cash, cash equivalents and restricted cash at beginning of period Cash, cash equivalents and restricted cash at end of period Total cash, cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Schedule of Finite-Lived Intangible Assets [Table] Intangible Asset, Finite-Lived [Table] Accounts payable Increase (Decrease) in Accounts Payable Accrued other Other Accrued Liabilities, Current Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Number of annual license fee payments Business Combination, Number Of Annual License Fee Payments Business Combination, Number Of Annual License Fee Payments Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Non-NEOs Non-NEOs [Member] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Acquisition consideration Payments to Acquire Businesses, Gross Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Compensation expense Labor and Related Expense 2028 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Two Employee stock purchase plan Common stock available for the Employee Stock Purchase Plan Employee Stock [Member] Customer [Domain] Customer [Domain] Proceeds from maturity of short-term investments Proceeds from Maturities, Prepayments and Calls of Held-to-Maturity Securities Basic (in USD per share) Basic EPS (in USD per share) Earnings Per Share, Basic Measurement Input Type [Axis] Measurement Input Type [Axis] Current portion of deferred revenue Contract with Customer, Liability, Current Total current assets Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Insider Trading Arrangements [Line Items] Acquired Indefinite-lived Intangible Assets [Line Items] Intangible Asset, Indefinite-Lived, Acquired [Line Items] Settlement of escrow claims Other Nonoperating Income (Expense), Escrow Claims Settlement Other Nonoperating Income (Expense), Escrow Claims Settlement Cost of revenue Cost of revenue Cost of Revenue Award Type [Axis] Award Type [Axis] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Accumulated deficit Retained Earnings (Accumulated Deficit) Product and Service [Axis] Product and Service [Axis] Restricted cash Restricted Cash, Noncurrent Issuance of loan receivable Payments to Acquire Loans Receivable Revaluation of acquisition-related contingent consideration Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease) Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Common Stock Common Stock [Member] Intangible asset amortization - operating expenses Intangible Asset Amortization [Member] Intangible Asset Amortization Acquisition-related contingent consideration, net of current portion Acquisition-related contingent consideration Contingent consideration Business Combination, Contingent Consideration, Liability Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Cover [Abstract] Cover [Abstract] Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Concentration risk Concentration Risk, Percentage Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Equity Awards Adjustments Equity Awards Adjustments [Member] Total liabilities and stockholders’ equity Liabilities and Equity Shares of common stock subject to outstanding options Options Share-Based Payment Arrangement, Option [Member] Segments [Axis] Segments [Axis] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Tabular List, Table Tabular List [Table Text Block] Purchase of short-term investments Payments to Acquire Held-to-Maturity Securities Other income (loss), net  Total Other (income) loss, net Other Nonoperating Income (Expense) 2029 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Three 2026 remainder of year Intangible Asset, Finite-Lived, Estimated Amortization Expense, Remainder of Fiscal Year Name Awards Close in Time to MNPI Disclosures, Individual Name Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] General and administrative Total general and administrative General and Administrative Expense C2i C2i Genomics, Inc. [Member] C2i Genomics, Inc. Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Supplies Inventory, Raw Materials and Supplies, Gross Preferred stock, $0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of September 30, 2026 and December 31, 2025 Preferred Stock, Value, Issued Deposits for Post-closing Matters Deposits For Post-closing Matters [Member] Deposits For Post-closing Matters Testing revenue Testing [Member] Represents testing. Adjustment to Compensation: Adjustment to Compensation [Axis] Class of Stock [Domain] Class of Stock [Domain] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Other Testing Revenue Testing, Other [Member] Testing, Other Schedule of Reserved Shares of Common Stock for Issuance Schedule of Stock by Class [Table Text Block] Post-Closing Adjustments Post-Closing Adjustments [Member] Post-Closing Adjustments Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Total assets Assets, Fair Value Disclosure Short-Term Investments Investment, Policy [Policy Text Block] Name Measure Name Income Taxes Income Tax Disclosure [Text Block] Accounts payable Accounts Payable, Current Pay vs Performance Disclosure [Line Items] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Stock-based compensation expense (ESPP) Adjustments To Additional Paid In Capital, Share Based Compensation, ESPP Amount of increase in additional paid-in capital (APIC) resulting from ESPP stock-based compensation expense. Acquisition consideration Business Combination, Consideration Transferred Business combination, consideration transferred, escrow deposits release period Business Combination, Consideration Transferred, Escrow Deposits Release Period Business Combination, Consideration Transferred, Escrow Deposits Release Period Additional Paid-in Capital Additional Paid-in Capital [Member] Entity Filer Category Entity Filer Category Short-term investments Short-Term Investments Indefinite-lived Intangible Assets [Axis] Intangible Asset, Indefinite-Lived, Class [Axis] License fees and royalties Cost Of Revenue, License Fees And Royalties Cost Of Revenue, License Fees And Royalties Name Trading Arrangement, Individual Name Cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalent Operating lease expense Operating Lease, Expense Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Company Selected Measure Amount Company Selected Measure Amount Indefinite-lived Intangible Assets Acquired as Part of Business Combination [Table] Business Combination, Intangible Asset, Acquired, Indefinite-Lived [Table] Depreciation and amortization Depreciation, Depletion and Amortization Entity Address, Address Line Two Entity Address, Address Line Two Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Accounts and Financing Receivables [Table] Schedule of Stock by Class [Table] Stock, Class of Stock [Table] Current assets: Assets, Current [Abstract] Weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Non-PEO NEO Non-PEO NEO [Member] Entity Address, Address Line One Entity Address, Address Line One Income tax provision (benefit) Income tax expense (benefit) Income Tax Expense (Benefit) Effect of foreign currency on operations Gain (Loss), Foreign Currency Transaction, before Tax Effect of potentially dilutive common stock from: Dilutive Securities, Effect on Basic Earnings Per Share [Abstract] Product costs Cost of Product and Service Sold Customer Concentration Risk Customer Concentration Risk [Member] Product technology Technology-Based Intangible Assets [Member] Tecan Tecan [Member] Tecan Award Timing Method Award Timing Method [Text Block] Net (decrease) increase in cash, cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Other research and development expenses Other Research and Development Expense Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Maximum contingent consideration to be paid Business Combination, Contingent Consideration, Range of Outcomes, Maximum, Amount Triggering Event [Domain] Triggering Event \ [Domain] Triggering Event \ [Domain] Deferred tax liability Business Combination, Recognized Liability Assumed, Deferred Tax Liability Net income Net income Net income Net Income (Loss) Attributable to Parent Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] NanoString NanoString [Member] Represents NanoString. Statement [Table] Statement [Table] Restatement Determination Date: Restatement Determination Date [Axis] Proceeds from the exercise of common stock options and employee stock purchases Proceeds from Stock Options Exercised Certificates of deposit Certificates of Deposit [Member] Phil Febbo [Member] Phil Febbo Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Revenue: Revenues [Abstract] Cash Retention Cash Retention [Member] Cash Retention Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Prepaid expenses and other current assets Business Combination, Recognized Asset Acquired, Prepaid Expense and Other Asset, Current